Transfection of a Rat Cytochrome P450b cDNA Into C3H10T1/2CL8 Mouse Embryo Fibroblasts

Suzanne K. Hansen, Jeffrey A. Ross, Jill M. Siegfried, Sharon Leavitt, Kenneth Rudo, Robert Langenbach, Stephen Nesnow

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A cDNA clone of a rat cytochrome P450b gene was used to construct an expression vector driven by an SV40 promoter and containing a G418‐resistance selectable marker. This bifunctional plasmid (pJRSL 100) was transfected into the C3H 10T1/2CL8 mouse embryo fibroblast cell line. G418‐resistant clones were selected and tested for enhanced sensitivity to the carcinogen 2‐acetylaminofluorene (2‐AAF), a compound that does not normally induce cytotoxicity or morphological transformation in these cells. One subclone, 19P450b‐4, exhibited an increased cytotoxic response to 2‐AAF compared to the parental C3H10T1/2CL8 cells. DNA analyses of this subclone showed increased number of copies of the cytochrome P450b and the appearance of unique restriction fragment bands relative to parental and control transfected cells. This subclone also exhibited increased levels of mRNA complementary to the P450b cDNA. Metabolism studies of 2‐AAF in this subclone demonstrated an increase in the C‐hydroxylated metabolites 1‐, 3‐, 5/9‐, and 7‐hydroxy‐AAF compared with parental C3H 10T1/2CL8 cells. The results indicate that C3H 10T1/2CL8 cells can be transfected with gene/cDNAs to increase their metabolic competency and that such transfection may enhance the usefulness of the C3H 10T1/2CL8 cells in studies on chemically induced cytotoxicity and morphological transformation.

Original languageEnglish (US)
Pages (from-to)261-267
Number of pages7
JournalMolecular Carcinogenesis
Volume2
Issue number5
DOIs
StatePublished - Jan 1 1989

Fingerprint

Cytochromes
Transfection
Embryonic Structures
Complementary DNA
Fibroblasts
Clone Cells
Carcinogens
Genes
Plasmids
Cell Line
Messenger RNA
DNA

Keywords

  • 2‐acetylaminofluorene
  • Cytotoxicity
  • metabolism

Cite this

Transfection of a Rat Cytochrome P450b cDNA Into C3H10T1/2CL8 Mouse Embryo Fibroblasts. / Hansen, Suzanne K.; Ross, Jeffrey A.; Siegfried, Jill M.; Leavitt, Sharon; Rudo, Kenneth; Langenbach, Robert; Nesnow, Stephen.

In: Molecular Carcinogenesis, Vol. 2, No. 5, 01.01.1989, p. 261-267.

Research output: Contribution to journalArticle

Hansen, SK, Ross, JA, Siegfried, JM, Leavitt, S, Rudo, K, Langenbach, R & Nesnow, S 1989, 'Transfection of a Rat Cytochrome P450b cDNA Into C3H10T1/2CL8 Mouse Embryo Fibroblasts', Molecular Carcinogenesis, vol. 2, no. 5, pp. 261-267. https://doi.org/10.1002/mc.2940020506
Hansen, Suzanne K. ; Ross, Jeffrey A. ; Siegfried, Jill M. ; Leavitt, Sharon ; Rudo, Kenneth ; Langenbach, Robert ; Nesnow, Stephen. / Transfection of a Rat Cytochrome P450b cDNA Into C3H10T1/2CL8 Mouse Embryo Fibroblasts. In: Molecular Carcinogenesis. 1989 ; Vol. 2, No. 5. pp. 261-267.
@article{9b18689da01c46188ed70f7f3d56f4ce,
title = "Transfection of a Rat Cytochrome P450b cDNA Into C3H10T1/2CL8 Mouse Embryo Fibroblasts",
abstract = "A cDNA clone of a rat cytochrome P450b gene was used to construct an expression vector driven by an SV40 promoter and containing a G418‐resistance selectable marker. This bifunctional plasmid (pJRSL 100) was transfected into the C3H 10T1/2CL8 mouse embryo fibroblast cell line. G418‐resistant clones were selected and tested for enhanced sensitivity to the carcinogen 2‐acetylaminofluorene (2‐AAF), a compound that does not normally induce cytotoxicity or morphological transformation in these cells. One subclone, 19P450b‐4, exhibited an increased cytotoxic response to 2‐AAF compared to the parental C3H10T1/2CL8 cells. DNA analyses of this subclone showed increased number of copies of the cytochrome P450b and the appearance of unique restriction fragment bands relative to parental and control transfected cells. This subclone also exhibited increased levels of mRNA complementary to the P450b cDNA. Metabolism studies of 2‐AAF in this subclone demonstrated an increase in the C‐hydroxylated metabolites 1‐, 3‐, 5/9‐, and 7‐hydroxy‐AAF compared with parental C3H 10T1/2CL8 cells. The results indicate that C3H 10T1/2CL8 cells can be transfected with gene/cDNAs to increase their metabolic competency and that such transfection may enhance the usefulness of the C3H 10T1/2CL8 cells in studies on chemically induced cytotoxicity and morphological transformation.",
keywords = "2‐acetylaminofluorene, Cytotoxicity, metabolism",
author = "Hansen, {Suzanne K.} and Ross, {Jeffrey A.} and Siegfried, {Jill M.} and Sharon Leavitt and Kenneth Rudo and Robert Langenbach and Stephen Nesnow",
year = "1989",
month = "1",
day = "1",
doi = "10.1002/mc.2940020506",
language = "English (US)",
volume = "2",
pages = "261--267",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Transfection of a Rat Cytochrome P450b cDNA Into C3H10T1/2CL8 Mouse Embryo Fibroblasts

AU - Hansen, Suzanne K.

AU - Ross, Jeffrey A.

AU - Siegfried, Jill M.

AU - Leavitt, Sharon

AU - Rudo, Kenneth

AU - Langenbach, Robert

AU - Nesnow, Stephen

PY - 1989/1/1

Y1 - 1989/1/1

N2 - A cDNA clone of a rat cytochrome P450b gene was used to construct an expression vector driven by an SV40 promoter and containing a G418‐resistance selectable marker. This bifunctional plasmid (pJRSL 100) was transfected into the C3H 10T1/2CL8 mouse embryo fibroblast cell line. G418‐resistant clones were selected and tested for enhanced sensitivity to the carcinogen 2‐acetylaminofluorene (2‐AAF), a compound that does not normally induce cytotoxicity or morphological transformation in these cells. One subclone, 19P450b‐4, exhibited an increased cytotoxic response to 2‐AAF compared to the parental C3H10T1/2CL8 cells. DNA analyses of this subclone showed increased number of copies of the cytochrome P450b and the appearance of unique restriction fragment bands relative to parental and control transfected cells. This subclone also exhibited increased levels of mRNA complementary to the P450b cDNA. Metabolism studies of 2‐AAF in this subclone demonstrated an increase in the C‐hydroxylated metabolites 1‐, 3‐, 5/9‐, and 7‐hydroxy‐AAF compared with parental C3H 10T1/2CL8 cells. The results indicate that C3H 10T1/2CL8 cells can be transfected with gene/cDNAs to increase their metabolic competency and that such transfection may enhance the usefulness of the C3H 10T1/2CL8 cells in studies on chemically induced cytotoxicity and morphological transformation.

AB - A cDNA clone of a rat cytochrome P450b gene was used to construct an expression vector driven by an SV40 promoter and containing a G418‐resistance selectable marker. This bifunctional plasmid (pJRSL 100) was transfected into the C3H 10T1/2CL8 mouse embryo fibroblast cell line. G418‐resistant clones were selected and tested for enhanced sensitivity to the carcinogen 2‐acetylaminofluorene (2‐AAF), a compound that does not normally induce cytotoxicity or morphological transformation in these cells. One subclone, 19P450b‐4, exhibited an increased cytotoxic response to 2‐AAF compared to the parental C3H10T1/2CL8 cells. DNA analyses of this subclone showed increased number of copies of the cytochrome P450b and the appearance of unique restriction fragment bands relative to parental and control transfected cells. This subclone also exhibited increased levels of mRNA complementary to the P450b cDNA. Metabolism studies of 2‐AAF in this subclone demonstrated an increase in the C‐hydroxylated metabolites 1‐, 3‐, 5/9‐, and 7‐hydroxy‐AAF compared with parental C3H 10T1/2CL8 cells. The results indicate that C3H 10T1/2CL8 cells can be transfected with gene/cDNAs to increase their metabolic competency and that such transfection may enhance the usefulness of the C3H 10T1/2CL8 cells in studies on chemically induced cytotoxicity and morphological transformation.

KW - 2‐acetylaminofluorene

KW - Cytotoxicity

KW - metabolism

UR - http://www.scopus.com/inward/record.url?scp=0024829840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024829840&partnerID=8YFLogxK

U2 - 10.1002/mc.2940020506

DO - 10.1002/mc.2940020506

M3 - Article

VL - 2

SP - 261

EP - 267

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 5

ER -